Ken Griffin Prestige Consumer Healthcare Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,300 shares of PBH stock, worth $494,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,300

Previous 1,400 350.0%

Holding current value

$494,928

Previous $96,000 372.92%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$65.26 - $75.5 $5.13 Million - $5.94 Million	-78,657 Reduced 77.78%	22,465 $1.62 Million
Q2 2024 Aug 14, 2024	SELL	$62.62 - $71.76 $5.63 Million - $6.45 Million	-89,905 Reduced 47.06%	101,122 $6.96 Million
Q1 2024 May 15, 2024	BUY	$58.76 - $75.07 $9.99 Million - $12.8 Million	170,031 Added 809.83%	191,027 $13.9 Million
Q4 2023 Feb 14, 2024	SELL	$57.0 - $61.94 $5.9 Million - $6.41 Million	-103,545 Reduced 83.14%	20,996 $1.29 Million
Q3 2023 Nov 14, 2023	BUY	$56.7 - $68.29 $3.87 Million - $4.67 Million	68,328 Added 121.55%	124,541 $7.12 Million
Q2 2023 Aug 14, 2023	SELL	$56.28 - $63.76 $319,726 - $362,220	-5,681 Reduced 9.18%	56,213 $3.34 Million
Q1 2023 May 15, 2023	SELL	$58.41 - $67.05 $568,738 - $652,865	-9,737 Reduced 13.59%	61,894 $3.88 Million
Q4 2022 Feb 14, 2023	BUY	$49.75 - $63.89 $1.68 Million - $2.16 Million	33,835 Added 89.52%	71,631 $4.48 Million
Q3 2022 Nov 14, 2022	SELL	$48.72 - $61.12 $755,793 - $948,154	-15,513 Reduced 29.1%	37,796 $1.88 Million
Q2 2022 Aug 15, 2022	SELL	$52.06 - $58.9 $5.83 Million - $6.6 Million	-112,042 Reduced 67.76%	53,309 $3.14 Million
Q1 2022 May 16, 2022	BUY	$52.94 - $61.88 $5.13 Million - $6 Million	96,891 Added 141.53%	165,351 $8.75 Million
Q4 2021 Feb 14, 2022	BUY	$55.41 - $63.3 $2.38 Million - $2.71 Million	42,875 Added 167.58%	68,460 $4.15 Million
Q3 2021 Nov 15, 2021	SELL	$51.0 - $60.54 $915,807 - $1.09 Million	-17,957 Reduced 41.24%	25,585 $1.44 Million
Q2 2021 Aug 16, 2021	SELL	$42.92 - $53.03 $109,617 - $135,438	-2,554 Reduced 5.54%	43,542 $2.27 Million
Q1 2021 May 17, 2021	SELL	$36.16 - $47.63 $739,869 - $974,557	-20,461 Reduced 30.74%	46,096 $2.03 Million
Q4 2020 Feb 16, 2021	BUY	$32.69 - $37.69 $980,601 - $1.13 Million	29,997 Added 82.05%	66,557 $2.32 Million
Q3 2020 Nov 16, 2020	SELL	$34.54 - $40.79 $1.45 Million - $1.71 Million	-41,937 Reduced 53.42%	36,560 $1.33 Million
Q2 2020 Aug 14, 2020	BUY	$36.63 - $44.07 $694,504 - $835,567	18,960 Added 31.85%	78,497 $2.95 Million
Q1 2020 May 15, 2020	SELL	$29.5 - $45.96 $351,728 - $547,981	-11,923 Reduced 16.68%	59,537 $2.18 Million
Q4 2019 Feb 14, 2020	BUY	$33.75 - $41.12 $893,902 - $1.09 Million	26,486 Added 58.89%	71,460 $2.89 Million
Q3 2019 Nov 14, 2019	BUY	$29.93 - $36.8 $916,606 - $1.13 Million	30,625 Added 213.43%	44,974 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$27.65 - $31.68 $4.15 Million - $4.76 Million	-150,096 Reduced 91.27%	14,349 $455,000
Q1 2019 May 15, 2019	SELL	$26.79 - $31.72 $3.17 Million - $3.75 Million	-118,163 Reduced 41.81%	164,445 $0
Q4 2018 Feb 14, 2019	SELL	$29.28 - $41.29 $2.22 Million - $3.13 Million	-75,787 Reduced 21.15%	282,608 $8.73 Million
Q3 2018 Nov 13, 2018	BUY	$34.44 - $39.35 $1 Million - $1.15 Million	29,131 Added 8.85%	358,395 $0
Q2 2018 Aug 10, 2018	BUY	$28.49 - $38.41 $3.12 Million - $4.2 Million	109,402 Added 49.76%	329,264 $0
Q1 2018 May 11, 2018	BUY	$32.94 - $46.03 $4.1 Million - $5.73 Million	124,560 Added 130.7%	219,862 $7.41 Million
Q4 2017 Feb 09, 2018	BUY	$40.63 - $50.91 $3.62 Million - $4.54 Million	89,133 Added 1444.85%	95,302 $4.23 Million
Q3 2017 Nov 09, 2017	BUY	$48.69 - $53.63 $300,368 - $330,843	6,169	6,169 $309,000

Others Institutions Holding PBH

# of Institutions

338

Shares Held

50.2M

Call Options Held

6.3K

Put Options Held

View Full List

About Prestige Consumer Healthcare Inc.

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $3.91B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

More about PBH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account